These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21379378)

  • 21. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.
    Cornell M; Grimsrud A; Fairall L; Fox MP; van Cutsem G; Giddy J; Wood R; Prozesky H; Mohapi L; Graber C; Egger M; Boulle A; Myer L;
    AIDS; 2010 Sep; 24(14):2263-70. PubMed ID: 20683318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique.
    Shepherd BE; Blevins M; Vaz LM; Moon TD; Kipp AM; José E; Ferreira FG; Vermund SH
    Am J Epidemiol; 2013 Sep; 178(5):819-28. PubMed ID: 23785113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
    Grimwood A; Fatti G; Mothibi E; Malahlela M; Shea J; Eley B
    J Int AIDS Soc; 2012 May; 15(2):17381. PubMed ID: 22713255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
    Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
    PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High risk of loss to follow-up among South African children on ART during transfer, a retrospective cohort analysis with community tracing.
    Teasdale CA; Sogaula N; Yuengling KA; Peters ZJ; Mutiti A; Pepeta L; Abrams EJ
    J Int AIDS Soc; 2017 Jun; 20(1):21748. PubMed ID: 28691440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating retention in HIV care accounting for clinic transfers using electronic medical records: evidence from a large antiretroviral treatment programme in the Western Cape, South Africa.
    Bengtson AM; Colvin C; Kirwa K; Cornell M; Lurie MN
    Trop Med Int Health; 2020 Aug; 25(8):936-943. PubMed ID: 32406961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.
    Lawn SD; Myer L; Harling G; Orrell C; Bekker LG; Wood R
    Clin Infect Dis; 2006 Sep; 43(6):770-6. PubMed ID: 16912954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.
    Mutevedzi PC; Lessells RJ; Newell ML
    Trop Med Int Health; 2013 Aug; 18(8):934-41. PubMed ID: 23731253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.
    Egger M; Spycher BD; Sidle J; Weigel R; Geng EH; Fox MP; MacPhail P; van Cutsem G; Messou E; Wood R; Nash D; Pascoe M; Dickinson D; Etard JF; McIntyre JA; Brinkhof MW;
    PLoS Med; 2011 Jan; 8(1):e1000390. PubMed ID: 21267057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
    Clouse K; Pettifor A; Maskew M; Bassett J; Van Rie A; Gay C; Behets F; Sanne I; Fox MP
    AIDS; 2013 Feb; 27(4):645-50. PubMed ID: 23169326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti.
    McNairy ML; Joseph P; Unterbrink M; Galbaud S; Mathon JE; Rivera V; Jannat-Khah D; Reif L; Koenig SP; Domercant JW; Johnson W; Fitzgerald DW; Pape JW
    PLoS One; 2017; 12(4):e0175521. PubMed ID: 28437477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey.
    Wubshet M; Berhane Y; Worku A; Kebede Y
    PLoS One; 2013; 8(3):e59197. PubMed ID: 23527132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist Among HIV-infected Infants and Young Children.
    Abrams EJ; Woldesenbet S; Soares Silva J; Coovadia A; Black V; Technau KG; Kuhn L
    Pediatr Infect Dis J; 2017 Jun; 36(6):595-601. PubMed ID: 28027287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    Anderegg N; Johnson LF; Zaniewski E; Althoff KN; Balestre E; Law M; Nash D; Shepherd BE; Yiannoutsos CT; Egger M;
    AIDS; 2017 Apr; 31 Suppl 1(Suppl 1):S31-S40. PubMed ID: 28296798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study.
    Russell EC; Charalambous S; Pemba L; Churchyard GJ; Grant AD; Fielding K
    BMC Public Health; 2010 Jul; 10():433. PubMed ID: 20653940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria.
    Onoka CA; Uzochukwu BS; Onwujekwe OE; Chukwuka C; Ilozumba J; Onyedum C; Nwobi EA; Onwasigwe C
    Pathog Glob Health; 2012 Mar; 106(1):46-54. PubMed ID: 22595274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.
    Brinkhof MW; Pujades-Rodriguez M; Egger M
    PLoS One; 2009 Jun; 4(6):e5790. PubMed ID: 19495419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.